Wells Fargo & Company Lyra Therapeutics, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,744 shares of LYRA stock, worth $4,948. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,744

Previous 17,596 40.62%

Holding current value

$4,948

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.17 - $0.28 $1,215 - $2,001	7,148 Added 40.62%	24,744 $5,000
Q3 2024 Nov 13, 2024	SELL	$0.24 - $0.34 $5 - $7	-22 Reduced 0.12%	17,596 $4,000
Q2 2024 Aug 13, 2024	BUY	$0.26 - $6.25 $4,515 - $108,543	17,367 Added 6919.12%	17,618 $4,000
Q1 2024 May 10, 2024	BUY	$4.55 - $6.53 $18 - $26	4 Added 1.62%	251 $1,000
Q4 2023 Feb 09, 2024	BUY	$2.82 - $5.24 $73 - $136	26 Added 11.76%	247 $1,000
Q3 2023 Nov 13, 2023	BUY	$2.95 - $4.8 $300 - $489	102 Added 85.71%	221 $0
Q2 2023 Aug 15, 2023	BUY	$1.98 - $4.33 $9 - $21	5 Added 4.39%	119 $0
Q1 2023 May 12, 2023	BUY	$1.95 - $3.09 $1 - $3	1 Added 0.88%	114 $0
Q4 2022 Feb 13, 2023	BUY	$2.44 - $5.42 $7 - $16	3 Added 2.73%	113 $0
Q3 2022 Nov 14, 2022	SELL	$4.95 - $6.6 $4 - $6	-1 Reduced 0.9%	110 $1,000
Q2 2022 Aug 12, 2022	SELL	$4.12 - $7.51 $1,755 - $3,199	-426 Reduced 79.33%	111 $1,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $84 - $132	14 Added 2.68%	537 $5,000
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $10,793 - $19,665	-1,562 Reduced 74.92%	523 $4,000
Q1 2021 May 13, 2021	SELL	$10.38 - $15.61 $14,905 - $22,415	-1,436 Reduced 40.78%	2,085 $24,000
Q4 2020 Feb 09, 2021	BUY	$9.28 - $13.88 $22,624 - $33,839	2,438 Added 225.12%	3,521 $40,000
Q3 2020 Nov 05, 2020	SELL	$10.61 - $13.96 $10,620 - $13,973	-1,001 Reduced 48.03%	1,083 $12,000
Q2 2020 Aug 13, 2020	BUY	$10.91 - $18.56 $22,736 - $38,679	2,084 New	2,084 $24,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

26.2M

Call Options Held

21K

Put Options Held

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.37M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Lyra Therapeutics, Inc. Transaction History